Meridian Bioscience Inc
VIVO
VIVO was delisted on the 30th of January, 2023.
191 hedge funds and large institutions have $657M invested in Meridian Bioscience Inc in 2020 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 65 increasing their positions, 59 reducing their positions, and 34 closing their positions.
64% more call options, than puts
Call options by funds: $2.7M | Put options by funds: $1.65M
10% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 59
9% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 34
0% more funds holding
Funds holding: 191 → 191 (0)
28% less capital invested
Capital invested by funds: $915M → $657M (-$258M)
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FP
Foundry Partners
Minneapolis,
Minnesota
|
+$5.61M |
| 2 |
RA
Royce & Associates
New York
|
+$4.82M |
| 3 |
CEI
Clark Estates Inc
New York
|
+$4.28M |
| 4 |
Charles Schwab
San Francisco,
California
|
+$3.99M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$3.92M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$12.9M |
| 2 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$5.96M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
-$5.9M |
| 4 |
Renaissance Technologies
New York
|
-$5.25M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$3.9M |
VIVO Hedge Fund Activity: Q3 2020 in Review
191 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q3 2020, worth a combined $657M — down 28% from $915M a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new VIVO positions and 34 closed out — a net gain of 3 holders — while 65 added to existing stakes and 59 trimmed.
The largest buyer was Foundry Partners, opening a new position worth an estimated $5.61M. The largest seller was Millennium Management, cutting an estimated $12.9M.
- 191 institutional investors held Meridian Bioscience Inc (VIVO) as of Q3 2020, unchanged from Q2 2020.
- Funds reported $657M of Meridian Bioscience Inc stock for Q3 2020, down 28% quarter-over-quarter.
- 37 funds opened new Meridian Bioscience Inc positions in Q3 2020 and 34 closed out, a net change of +3 holders.
- The largest Meridian Bioscience Inc buyer in Q3 2020 was Foundry Partners, an estimated $5.61M added.
- The largest Meridian Bioscience Inc seller in Q3 2020 was Millennium Management, an estimated $12.9M sold.
Based on aggregated 13F filings for Q3 2020.